Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: Analyses from the 7-year PRECiSE 3 study

W. J. Sandborn, G. Y. Melmed, D. P.B. McGovern, E. V. Loftus, J. M. Choi, J. H. Cho, B. Abraham, A. Gutierrez, G. Lichtenstein, S. D. Lee, C. W. Randall, D. A. Schwartz, M. Regueiro, C. A. Siegel, M. Spearman, G. Kosutic, B. Pierre-Louis, J. Coarse, S. Schreiber

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: Analyses from the 7-year PRECiSE 3 study'. Together they form a unique fingerprint.

Medicine & Life Sciences